학술논문
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer
Document Type
Article
Author
Kuemmel, S.; Campone, M.; Loirat, D.; Lopez, R.L.; Thaddeus Beck, J.; de Laurentiis, M.; Im, S.-A.; Kim, S.-B.; Kwong, A.; Steger, G.G.; Adelantado, E.Z.; Duhoux, F.P.; Greil, R.; Kuter, I.; Lu, Y.-S.; Tibau, A.; Özgüroğlu, M.; Scholz, C.W.; Singer, C.F.; Vega, E.; Wimberger, P.; Zamagni, C.; Couillebault, X.-M.; Guerreiro, N.; Sand-Dejmek, J.; Fan, L.; Mataraza, J.; Chan, A.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 January 2022, 28(1):106-115)
Subject
Language
English
ISSN
15573265
10780432
10780432